Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3899/jrheum.120857 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Giant Partially Thrombosed Coronary Aneurysm in Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 in Children.
Case Rep Med
September 2022
Pediatric Cradiologist, Pediatric Congenital Cardiac Sonographer, Hospital Universitario de Neiva, Neiva, Surcolombiana University, Neiva, Colombia.
Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious condition which usually develops 4 to 6 weeks after SARS-CoV-2 infection in a genetically predisposed individual. Clinical features are heterogeneous and include fever, respiratory compromise, mucocutaneous involvement with conjunctival abnormalities and erythematous exanthem, abdominal pain, and diarrhea. Neurologic and cardiovascular symptoms can also develop, including coronary artery dilatation.
View Article and Find Full Text PDFListeria myopericarditis associated with right atrial mural thrombus: a case report.
Eur Heart J Case Rep
August 2020
Department of Cardiology, Northumbria Healthcare NHS Foundation Trust, Northumbria Specialist Care Emergency Hospital, Northumbria Way, Northumberland NE23 6NZ, UK.
Background: Pericarditis is a common cardiology presentation, most often due to a viral or idiopathic cause. Listeria as a cause of pericarditis is rare. Listeria is an infection that is readily treatable with antibiotics following accurate identification.
View Article and Find Full Text PDFGiant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock.
Case Rep Cardiol
August 2015
Department of Cardiology, New York University Langone Medical Center, New York, NY 10016, USA.
Giant cell myocarditis is a rare and often fatal disease. The most obvious presentation often described in the literature is one of rapid hemodynamic deterioration due to cardiogenic shock necessitating urgent consideration of mechanical circulatory support and heart transplantation. We present the case of a 60-year-old man whose initial presentation was consistent with myopericarditis but who went on to develop a rapid decline in left ventricular systolic function without overt hemodynamic compromise or dramatic symptomatology.
View Article and Find Full Text PDFGiant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction.
Can J Cardiol
September 2013
Divisions of Cardiology, Cardiac Surgery and Nursing, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
A young woman thought to have seronegative rheumatoid arthritis developed Stevens-Johnson syndrome after treatment with sulfasalazine; this resolved with prednisone. Later she was found to be HLA-B27-positive in keeping with a spondyloarthropathy. Soon afterward, she developed clinical myopericarditis and cardiogenic shock that responded initially to methylprednisolone and intravenous immunoglobulin, but recurred.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!